As of 2022, MUWRP had successfully conducted and completed five phase I/II HIV vaccine clinical trials, five for Ebola and Marburg, while one phase I/II Schistosomiasis and one phase III COVID-19 vaccineclinical trial are ongoing.
Discussion:
The completed vaccine trials provided critical scientific knowledge on the safety and immunogenicity of investigational products which informed the design of better vaccines for diseases of global health importance.
Conclusion:
Academia, through establishment of appropriate partnerships can contribute to the identification of solutions to complex public health challenges